top of page

ACKNOWLEDGEMENTS

The Organizing Committee wishes to acknowledge the following companies whose generous support has made this Conference possible:

 

SPONSORS

BIAL

Biocodex, France

Eisai Inc., USA                

GW Pharmaceuticals PLC, UK

LivaNova Belgium N.V., Belgium

Medtronic, USA

Novartis Farma S.P.A., Italy

Ontario Brain Institute, Canada

Ovid Therapeutics Inc., USA 

Pfizer Inc., USA

Proximagen LLC, USA

Sage Therapeutics, Inc, USA

SK Biopharmaceuticals, USA

UCB BioPharma sprl., Belgium

Vitaflo International Ltd, UK

Zogenix Inc., USA

 

 

CONTRIBUTORS

BioMarin International Limited, Ireland

Biscayne Pharmaceuticals, Inc., USA

Boehringer Ingelheim Vetmedica GmbH, Germany

Engage Therapeutics
Empatica Inc, USA

Marinus Pharmaceuticals, Inc., USA

Neurelis, USA

NeuroPace, Inc., USA

PIQUR Therapeutics AG, Switzerland 

Yissum R&D Company of the Hebrew University of Jerusalem

Xenon Pharmaceuticals Inc.

bottom of page